Pharmaceutical Contract Sales Outsourcing Market (By Service: Personal Promotion, Non-personal Promotion, Others; By Therapeutic Area: Oncology, Cardiovascular Disorders, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

The global pharmaceutical contract sales outsourcing market size was valued at USD 7.1 billion in 2020 and is expected to reach USD 14.5 billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.

Pharmaceutical Contract Sales Outsourcing Market Size 2021 to 2030

Increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations, as it offers cost controls, better results, and flexibility in terms of operations is anticipated to drive the global pharmaceutical contract sales outsourcing (CSO) market.

Digitalization of Services Provided by CSOs to Propel Market

Improved and advanced services provided by CSOs such as in the field of non-personal promotions are anticipated to drive the global market during the forecast period. Large as well as small pharmaceutical companies are looking for drugs to cost effectively and quickly enter their pipelines and CSOs play an important role in this endeavor.

The rise in virtual detailing in outsourcing services is increasing dependence on CSO services. The surge in the usage of teledetailng propels the non-personal promotion of outsourcing. These advanced functions, including sales force and customer support are well-established in a CSO, and hence, can help the brand to get market recognition faster.

Key Segments

In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others. The personal promotion segment has been split into promotional sales team, key account management, and vacancy management. The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others

Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others.

Base on region, the North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period. Well-established healthcare, early adoption of technologically advanced services, and increase in acceptance & demand for pharmaceutical contract sales outsourcing services are the major factors likely to drive the market in the region during the forecast period

The market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2030.

Key Players

The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market: Segmentation

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Service

  • Personal Promotion
      • Promotional Sales Team
        • Dedicated Sales Team
        • Syndicated Sales Team
      • Key Account Management
      • Vacancy Management
  • Non-personal Promotion
      • Tele-detailing
      • Interactive E-detailing
      • Customer Service
      • Medical Science Liaisons
      • Patient Engagement Services
      • Others (telesampling)
  • Others (Field Management/Reporting and Sales Training)

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Therapeutic Area

    • Cardiovascular Disorders
    • Oncology
    • Metabolic Disorders
    • Neurology
    • Orthopedic Diseases
    • Infectious Diseases
    • Others

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Region

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
  • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia & New Zealand
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

This report focuses on pharmaceutical contract sales outsourcing market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall pharmaceutical contract sales outsourcing market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global pharmaceutical contract sales outsourcing market.

The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.

In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the pharmaceutical contract sales outsourcing market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the pharmaceutical contract sales outsourcing market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Pharmaceutical contract sales outsourcing market.

Market Segments: This part of the report discusses about product, application and other segments of the pharmaceutical contract sales outsourcing market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global pharmaceutical contract sales outsourcing market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the pharmaceutical contract sales outsourcing market.

The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.

Competitive Landscape and Market Share Analysis

The pharmaceutical contract sales outsourcing market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, pharmaceutical contract sales outsourcing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the pharmaceutical contract sales outsourcing sales, revenue and market share for each player covered in this report.

  • Crucial data regarding the major contenders, product portfolio, market remuneration, and production patterns are documented in the report.
  • The report presents the pricing models followed by each company, alongside the gross margins and market share held by each company.

Research Methodology

The research methodology adopted by analysts for compiling the global pharmaceutical contract sales outsourcing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global pharmaceutical contract sales outsourcing market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Pharmaceutical Contract Sales Outsourcing Market, By Service

7.1.  Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021-2030

7.1.1.     Personal Promotion

7.1.1.1.          Market Revenue and Forecast (2016-2030)

7.1.2.     Non-personal Promotion

7.1.2.1.          Market Revenue and Forecast (2016-2030)

7.1.3.     Others (Field Management/Reporting and Sales Training)

7.1.3.1.          Market Revenue and Forecast (2016-2030)

Chapter 8.    Global Pharmaceutical Contract Sales Outsourcing Market, By Therapeutic Area

8.1.  Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021-2030

8.1.1.     Cardiovascular Disorders

8.1.1.1.          Market Revenue and Forecast (2016-2030)

8.1.2.     Oncology

8.1.2.1.          Market Revenue and Forecast (2016-2030)

8.1.3.     Metabolic Disorders

8.1.3.1.          Market Revenue and Forecast (2016-2030)

8.1.4.     Neurology

8.1.5.     Market Revenue and Forecast (2016-2030)

8.1.6.     Orthopedic Diseases

8.1.6.1.          Market Revenue and Forecast (2016-2030)

8.1.7.     Infectious Diseases

8.1.7.1.          Market Revenue and Forecast (2016-2030)

8.1.8.     Others

8.1.8.1.          Market Revenue and Forecast (2016-2030)

Chapter 9.    Global Pharmaceutical Contract Sales Outsourcing Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, by Service (2016-2030)

9.1.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.1.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.1.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, by Service (2016-2030)

9.2.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.2.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, by Service (2016-2030)

9.3.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.3.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, by Service (2016-2030)

9.4.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.5.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, by Service (2016-2030)

9.4.6.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, by Service (2016-2030)

9.5.2.     Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, by Service (2016-2030)

9.5.3.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, by Service (2016-2030)

9.5.4.2.          Market Revenue and Forecast, by Therapeutic Area (2016-2030)

Chapter 10.   Company Profiles

10.1.                 Ashfield (UDG Healthcare plc)

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 inVentiv Health

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Inc. (Syneos Health)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 IQVIA

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Granard Pharmaceutical Sales & Marketing

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Vanguard Pharma Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 GTS Solution

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 EVERSANA

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 MaBiCo

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              MaBiCo

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers